$NRC
NATIONAL RESEARCH CORP

2024 Q4 Form 10-Q Financial Statement

#000143774924034119 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $35.82M
YoY Change -5.6%
Cost Of Revenue $15.31M
YoY Change 4.61%
Gross Profit $20.51M
YoY Change -11.99%
Gross Profit Margin 57.27%
Selling, General & Admin $10.99M
YoY Change -6.9%
% of Gross Profit 53.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.546M
YoY Change -0.26%
% of Gross Profit 7.54%
Operating Expenses $10.99M
YoY Change -6.9%
Operating Profit $7.980M
YoY Change -19.84%
Interest Expense -$672.0K
YoY Change -520.0%
% of Operating Profit -8.42%
Other Income/Expense, Net -$684.0K
YoY Change -914.29%
Pretax Income $7.296M
YoY Change -27.32%
Income Tax $1.608M
% Of Pretax Income 22.04%
Net Earnings $5.688M
YoY Change -27.78%
Net Earnings / Revenue 15.88%
Basic Earnings Per Share $0.24
Diluted Earnings Per Share $0.24
COMMON SHARES
Basic Shares Outstanding 23.48M 23.87M
Diluted Shares Outstanding 23.75M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.461M
YoY Change -8.92%
Cash & Equivalents $3.461M
Short-Term Investments
Other Short-Term Assets $664.0K
YoY Change 79.95%
Inventory
Prepaid Expenses $4.871M
Receivables $11.06M
Other Receivables $645.0K
Total Short-Term Assets $20.70M
YoY Change -16.34%
LONG-TERM ASSETS
Property, Plant & Equipment $36.32M
YoY Change 41.94%
Goodwill $66.21M
YoY Change 7.46%
Intangibles $2.713M
YoY Change 80.15%
Long-Term Investments
YoY Change
Other Assets $5.856M
YoY Change 51.08%
Total Long-Term Assets $111.1M
YoY Change 16.46%
TOTAL ASSETS
Total Short-Term Assets $20.70M
Total Long-Term Assets $111.1M
Total Assets $131.8M
YoY Change 9.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.588M
YoY Change 81.74%
Accrued Expenses $6.279M
YoY Change 36.41%
Deferred Revenue $17.30M
YoY Change 6.55%
Short-Term Debt $5.000M
YoY Change 0.0%
Long-Term Debt Due $3.721M
YoY Change -20.83%
Total Short-Term Liabilities $44.28M
YoY Change 8.51%
LONG-TERM LIABILITIES
Long-Term Debt $44.91M
YoY Change 216.27%
Other Long-Term Liabilities $3.564M
YoY Change 29.51%
Total Long-Term Liabilities $48.47M
YoY Change 1661.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.28M
Total Long-Term Liabilities $48.47M
Total Liabilities $97.18M
YoY Change 56.07%
SHAREHOLDERS EQUITY
Retained Earnings -$20.86M
YoY Change -42.83%
Common Stock $180.1M
YoY Change 1.89%
Preferred Stock
YoY Change
Treasury Stock (at cost) $124.6M
YoY Change
Treasury Stock Shares
Shareholders Equity $34.62M
YoY Change
Total Liabilities & Shareholders Equity $131.8M
YoY Change 9.71%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $5.688M
YoY Change -27.78%
Depreciation, Depletion And Amortization $1.546M
YoY Change -0.26%
Cash From Operating Activities $9.422M
YoY Change -4.05%
INVESTING ACTIVITIES
Capital Expenditures $1.596M
YoY Change -64.3%
Acquisitions
YoY Change
Other Investing Activities -$4.833M
YoY Change
Cash From Investing Activities -$6.429M
YoY Change 43.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -17.00K
YoY Change -99.93%
NET CHANGE
Cash From Operating Activities 9.422M
Cash From Investing Activities -6.429M
Cash From Financing Activities -17.00K
Net Change In Cash 2.976M
YoY Change -115.94%
FREE CASH FLOW
Cash From Operating Activities $9.422M
Capital Expenditures $1.596M
Free Cash Flow $7.826M
YoY Change 46.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000070487
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Debt Instrument Variable Interest Rate Type Extensible Enumeration
DebtInstrumentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35929
dei Entity Registrant Name
EntityRegistrantName
National Research Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0634000
dei Entity Address Address Line1
EntityAddressAddressLine1
1245 Q Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Lincoln
dei Entity Address State Or Province
EntityAddressStateOrProvince
NE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
68508
dei City Area Code
CityAreaCode
402
dei Local Phone Number
LocalPhoneNumber
475-2525
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value
dei Trading Symbol
TradingSymbol
NRC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23476040
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3461000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6653000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
75000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11059000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12378000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4871000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4228000 usd
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
645000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
161000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
664000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
940000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
20700000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
24360000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36320000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28205000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2713000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1471000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
66209000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
61614000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5856000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6787000 usd
CY2024Q3 us-gaap Assets
Assets
131798000 usd
CY2023Q4 us-gaap Assets
Assets
122437000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
3721000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7214000 usd
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5000000 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2588000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1301000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5392000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3953000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6279000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4893000 usd
CY2024Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
2817000 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
2906000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17301000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14834000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
222000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
506000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
673000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
880000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
44277000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36203000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
44910000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
29470000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4131000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4139000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
293000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3564000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3670000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
97175000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
73482000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31072144
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31002919
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23476040
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24219887
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
31000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
31000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
180061000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
178213000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20855000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30530000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7596104
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6783032
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
124614000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
98759000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
34623000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
48955000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
131798000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122437000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35819000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37945000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106154000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110579000 usd
CY2024Q3 us-gaap Direct Operating Costs
DirectOperatingCosts
15305000 usd
CY2023Q3 us-gaap Direct Operating Costs
DirectOperatingCosts
14633000 usd
us-gaap Direct Operating Costs
DirectOperatingCosts
42583000 usd
us-gaap Direct Operating Costs
DirectOperatingCosts
42222000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10988000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11802000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33459000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35552000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1546000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1555000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4506000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4469000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
27839000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
27990000 usd
us-gaap Costs And Expenses
CostsAndExpenses
80548000 usd
us-gaap Costs And Expenses
CostsAndExpenses
82243000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7980000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9955000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
25606000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
28336000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
34000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
256000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
103000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
779000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
706000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
160000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1866000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
594000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-684000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1791000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
158000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7296000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10039000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23815000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28494000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1608000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2163000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5592000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6381000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
5688000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
7876000 usd
us-gaap Profit Loss
ProfitLoss
18223000 usd
us-gaap Profit Loss
ProfitLoss
22113000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.9
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23721000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24560000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23820000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24574000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23745000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24695000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23868000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24715000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
48955000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
417855
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
17220000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
75283
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1752000 usd
CY2024Q1 nrc Apic Sharebased Payment Arrangement Increase Decrease For Cost Benefit Recognition
ApicSharebasedPaymentArrangementIncreaseDecreaseForCostBenefitRecognition
-36000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2865000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
6359000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
36945000 usd
CY2024Q2 nrc Apic Sharebased Payment Arrangement Increase Decrease For Cost Benefit Recognition
ApicSharebasedPaymentArrangementIncreaseDecreaseForCostBenefitRecognition
-57000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2024Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2865000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
6175000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
40198000 usd
CY2024Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
395217
CY2024Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8635000 usd
CY2024Q3 nrc Apic Sharebased Payment Arrangement Increase Decrease For Cost Benefit Recognition
ApicSharebasedPaymentArrangementIncreaseDecreaseForCostBenefitRecognition
189000 usd
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2817000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
5688000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
34623000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
72033000 usd
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
49296
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1983000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20938
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
300000 usd
CY2023Q1 nrc Apic Sharebased Payment Arrangement Increase Decrease For Cost Benefit Recognition
ApicSharebasedPaymentArrangementIncreaseDecreaseForCostBenefitRecognition
304000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2953000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6964000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
74665000 usd
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
43723
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1828000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
284000 usd
CY2023Q2 nrc Apic Sharebased Payment Arrangement Increase Decrease For Cost Benefit Recognition
ApicSharebasedPaymentArrangementIncreaseDecreaseForCostBenefitRecognition
305000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2949000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
7273000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
77750000 usd
CY2023Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
7384
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
313000 usd
CY2023Q3 nrc Apic Sharebased Payment Arrangement Increase Decrease For Cost Benefit Recognition
ApicSharebasedPaymentArrangementIncreaseDecreaseForCostBenefitRecognition
68000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.12
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
27509000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
7876000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
57872000 usd
us-gaap Profit Loss
ProfitLoss
18223000 usd
us-gaap Profit Loss
ProfitLoss
22113000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4506000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4469000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-118000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-721000 usd
nrc Reserve For Uncertain Tax Positions
ReserveForUncertainTaxPositions
211000 usd
nrc Reserve For Uncertain Tax Positions
ReserveForUncertainTaxPositions
250000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
96000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
677000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
23000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1752000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-91000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3257000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-212000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-800000 usd
nrc Increase Decrease In Operating Lease Assets And Lease Liabilities Net
IncreaseDecreaseInOperatingLeaseAssetsAndLeaseLiabilitiesNet
-9000 usd
nrc Increase Decrease In Operating Lease Assets And Lease Liabilities Net
IncreaseDecreaseInOperatingLeaseAssetsAndLeaseLiabilitiesNet
75000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
599000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
230000 usd
nrc Increase Decrease In Accrued Expenses Wages Bonuses And Profit Sharing
IncreaseDecreaseInAccruedExpensesWagesBonusesAndProfitSharing
1789000 usd
nrc Increase Decrease In Accrued Expenses Wages Bonuses And Profit Sharing
IncreaseDecreaseInAccruedExpensesWagesBonusesAndProfitSharing
493000 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-706000 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
392000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1559000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1040000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28246000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26405000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11004000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12009000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4833000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15837000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12008000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5044000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3373000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
17000000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
39000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
5000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
34000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
19000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
279000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
37000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
584000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
317000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
23548000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4100000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8636000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
33419000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15601000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35595000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3192000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21198000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6653000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25026000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3461000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3828000 usd
us-gaap Interest Paid Net
InterestPaidNet
1699000 usd
us-gaap Interest Paid Net
InterestPaidNet
600000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6270000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6484000 usd
nrc Stock Tendered Cashless Exercise Of Stock Options
StockTenderedCashlessExerciseOfStockOptions
1752000 usd
nrc Stock Tendered Cashless Exercise Of Stock Options
StockTenderedCashlessExerciseOfStockOptions
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2610000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1819000 usd
nrc Treasury Stock Value Repurchase Of Shares For Treasury In Accounts Payable And Accrued Expenses
TreasuryStockValueRepurchaseOfSharesForTreasuryInAccountsPayableAndAccruedExpenses
238000 usd
nrc Treasury Stock Value Repurchase Of Shares For Treasury In Accounts Payable And Accrued Expenses
TreasuryStockValueRepurchaseOfSharesForTreasuryInAccountsPayableAndAccruedExpenses
24000 usd
nrc Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Contingent Consideration Recorded
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationContingentConsiderationRecorded
776000 usd
nrc Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Contingent Consideration Recorded
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationContingentConsiderationRecorded
0 usd
CY2024Q3 nrc Incremental Costs Of Obtaining A Contract Deferred During Period
IncrementalCostsOfObtainingAContractDeferredDuringPeriod
297000 usd
CY2023Q3 nrc Incremental Costs Of Obtaining A Contract Deferred During Period
IncrementalCostsOfObtainingAContractDeferredDuringPeriod
69000 usd
nrc Incremental Costs Of Obtaining A Contract Deferred During Period
IncrementalCostsOfObtainingAContractDeferredDuringPeriod
608000 usd
nrc Incremental Costs Of Obtaining A Contract Deferred During Period
IncrementalCostsOfObtainingAContractDeferredDuringPeriod
301000 usd
CY2024Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1200000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1500000 usd
CY2024Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
249000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
345000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
783000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1061000 usd
CY2024Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
3000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
26000 usd
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
37000 usd
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
41000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
75000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-72000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
9000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
51000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
45000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
65000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
100000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
89000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
9000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
85000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
48742000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
36787000 usd
CY2024Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
48742000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
36403000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35819000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37945000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106154000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110579000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11059000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12378000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17301000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14834000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
41000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 usd
nrc Contract With Customer Liability Revenue Recognized From Deferred Revenue
ContractWithCustomerLiabilityRevenueRecognizedFromDeferredRevenue
14355000 usd
nrc Contract With Customer Liability Revenue Recognized From Deferred Revenue
ContractWithCustomerLiabilityRevenueRecognizedFromDeferredRevenue
14473000 usd
nrc Contract With Customer Liability Billings
ContractWithCustomerLiabilityBillings
15966000 usd
nrc Contract With Customer Liability Billings
ContractWithCustomerLiabilityBillings
15602000 usd
nrc Contract With Customer Asset Increase Due To Acquisition
ContractWithCustomerAssetIncreaseDueToAcquisition
948000 usd
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
83000 usd
us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
93000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-51000 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-89000 usd
nrc Contract With Customer Asset Increase Revenue Recognized Conditional Consideration
ContractWithCustomerAssetIncreaseRevenueRecognizedConditionalConsideration
10000 usd
nrc Contract With Customer Asset Increase Revenue Recognized Conditional Consideration
ContractWithCustomerAssetIncreaseRevenueRecognizedConditionalConsideration
29000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.22 pure
nrc Effective Income Tax Rate Change Share Based Compensation
EffectiveIncomeTaxRateChangeShareBasedCompensation
55000 usd
nrc Income Tax Reconciliation State Tax Changes
IncomeTaxReconciliationStateTaxChanges
241000 usd
CY2024Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
3721000 usd
CY2023Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
7214000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
111000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
103000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
44910000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29470000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
584000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
62328000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
714000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
61614000 usd
CY2024Q3 us-gaap Goodwill Gross
GoodwillGross
66923000 usd
CY2024Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
714000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
66209000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14134000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
12723000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12612000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12443000 usd
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2713000 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1471000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
76319000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63874000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39999000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35669000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36320000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28205000 usd
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
402822
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
275064
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
406713
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
268838
CY2024Q3 us-gaap Profit Loss
ProfitLoss
5688000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
7876000 usd
us-gaap Profit Loss
ProfitLoss
18223000 usd
us-gaap Profit Loss
ProfitLoss
22113000 usd
CY2024Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
-0 usd
CY2023Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
2000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
2000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
5000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5688000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7874000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18221000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22108000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23721000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24560000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23820000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24574000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.9
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5688000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7874000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18221000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22108000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23721000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24560000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23820000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24574000
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24000
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
135000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
48000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
141000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23745000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24695000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23868000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24715000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
nrc-20240930_cal.xml Edgar Link unprocessable
nrc-20240930_def.xml Edgar Link unprocessable
0001437749-24-034119-index-headers.html Edgar Link pending
0001437749-24-034119-index.html Edgar Link pending
0001437749-24-034119.txt Edgar Link pending
0001437749-24-034119-xbrl.zip Edgar Link pending
ex_739484.htm Edgar Link pending
ex_739485.htm Edgar Link pending
ex_739486.htm Edgar Link pending
ex_739487.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nrc-20240930.xsd Edgar Link pending
nrc20240930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
nrc-20240930_lab.xml Edgar Link unprocessable
nrc-20240930_pre.xml Edgar Link unprocessable
nrc20240930_10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending